DOCS Stock Analysis: Buy, Sell, or Hold?
DOCS - Doximity, Inc.
$37.29
-0.18 (-0.48%)
▼
5d:
-7.7%
30d:
-15.79%
90d:
-43.35%
HOLD
MODERATE Confidence
Last Updated: February 2, 2026
Earnings: Feb 05, 2026
1d
Get Alerted When DOCS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
2 traders called DOCS this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: DOCS shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: DOCS shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$60.31
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$37.45
0.4% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: DOCS is currently trading at $37.29, which is considered oversold relative to its 30-day fair value range of $39.29 to $44.48. From a valuation perspective, the stock is trading at a discount (Forward PE: 21.6) compared to its historical average (28.5). Remarkably, the market is currently pricing in an annual earnings decline of 8.8% over the next few years. This pessimistic expectation contrasts with the company's recent 40.9% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, DOCS is in a strong downtrend. The price is currently testing key support at $36.83. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: DOCS has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $63.00 (+68.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, DOCS is in a strong downtrend. The price is currently testing key support at $36.83. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: DOCS has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $63.00 (+68.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$39.29 -
$44.48
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 68.9% below Wall St target ($63.00)
- CAUTION: 5-day price weakness (-7.7%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$39.29 -
$44.48
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$36.83
Resistance Level
$42.13
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
21.61
Wall Street Target
$63.00
(+68.9%)
Revenue Growth (YoY)
23.2%
Earnings Growth (YoY)
40.9%
Profit Margin
40.7%
Valuation Discount vs History
-8.8% cheaper
PE vs Historical
21.6 vs 28.5
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-8.8%
(market-implied from PE analysis)
1-Year Target
$34.01
(-9%)
2-Year Target
$31.02
(-17%)
3-Year Target
$28.29
(-24%)
3-Yr Target (if PE normalizes)
(PE: 22→29)
$37.31
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.3, Growth: 9.9%)
$51.14
(+37%)
Base:
(SPY PE: 21.6, Growth: 9.9%)
$49.56
(+33%)
Bear:
(PE: 18.4, Growth: 9.9%)
$42.13
(+13%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (31x PE), but valuation improves significantly next year (22x PE) as earnings recover.
Trailing PE: 30.97 | Current EPS (TTM): $1.21
Bull Case
$58.78
(+58%)
Analyst growth 42.6%, PE expands to 34.1
Base Case
$53.44
(+43%)
Market implied 42.6%, PE stable at 31.0
Bear Case
$25.48
(-32%)
Severe decline -20.0%, PE contracts to 26.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 21.6 to 28.5
Stabilization Target:
$49.18
(+31.9%)
PE Expansion Potential:
+31.9%
Last updated: February 02, 2026 10:38 PM ET
Data refreshes hourly during market hours. Next update: 11:38 PM
Data refreshes hourly during market hours. Next update: 11:38 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DOCS showing a specific setup today?
Insider Activity (6 Months)
1
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Regina M Benjamin
SELL
5000 shares
2025-10-10
Timothy S Cabral
SELL
20000 shares
2025-09-24
Regina M Benjamin
SELL
5000 shares
2025-09-12
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$310 | 52 HOLD |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$31 | 55 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 64 BUY |
|
HQY
HealthEquity Inc |
STRONG BUY
14 analysts |
$119 | 64 BUY |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$29 | 49 HOLD |
